Enovis Quick Ratio (ENOV) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Enovis Corp  (NYSE: ENOV)

Enovis's Quick Ratio

ENOV's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2026, Quick Ratio deteriorated to 0.02 a new company low.

Within Medical Equipment & Supplies industry 199 other companies have achieved higher Quick Ratio than Enovis in third quarter 2026. While Quick Ratio total ranking has improved so far during the Q3 2026 to 4109, from total ranking in the second quarter 2026 at 4992.

Explain Quick Ratio?
How much Cash & cash equivalents ENOV´s has?
What are ENOV´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ENOV/financial-strength
https://api.csimarket.com/api/v1/companies/ENOV/fundamentals
https://api.csimarket.com/api/v1/companies/ENOV/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
ENOV Quick Ratio (Oct 02 2026)
Q3
(Jul 03 2026)
Q2
(Apr 03 2026)
Q1
(Dec 31 2025)
Q4
(Oct 03 2025)
Q3
Y / Y Current Liabilities Change 13.62 %
Y / Y Cash & cash equivalent Change -61.22 %
Quick Ratio MRQ 0.02
ENOV's Total Ranking # 4109
Seq. Current Liabilities Change -11.12 %
Seq. Cash & cash equivalent Change 3.78 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 200
Healthcare Sector # 902
Overall Market # 4293


Quick Ratio Statistics
High Average Low
1.51 0.27 0.02
(Dec 31 2021)   (Jul 03 2026)




Financial Statements
Enovis's Current Liabilities $ 654 Millions Visit ENOV's Balance sheet
Enovis's Cash & cash equivalent $ 13 Millions Visit ENOV's Balance sheet
Source of ENOV's Sales Visit ENOV's Sales by Geography


Cumulative Enovis's Quick Ratio

ENOV's Quick Ratio for the trailling 12 Months

ENOV Quick Ratio

(Oct 02 2026)
12 Months
(Jul 03 2026)
12 Months
(Apr 03 2026)
12 Months
(Dec 31 2025)
12 Months
(Oct 03 2025)
12 Months
Y / Y Current Liabilities TTM Growth 19.12 %
Y / Y Cash & cash equivalent TTM Growth -42.11 %
Quick Ratio TTM 0.04
Total Ranking TTM # 4119
Seq. Current Liabilities TTM Growth 3.08 %
Seq. Cash & cash equivalent TTM Growth -17.79 %


On the trailing twelve months basis Due to fall in Current Liabilities in the Q3 2026 to $653.83 millions, cumulative Quick Ratio decreased to 0.04 below the Enovis Corp average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 207 other companies have achieved higher Quick Ratio than Enovis. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 2203 to 4119.

Explain Quick Ratio?
How much Cash & cash equivalents ENOV´s has?
What are ENOV´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 208
Healthcare Sector # 912
Within the Market # 4119


trailing twelve months Quick Ratio Statistics
High Average Low
0.39 0.2 0.05
(Jul 01 2022)   (Jul 03 2026)




Companies with similar Quick Ratio in the quarter ending Oct 02 2026, within Medical Equipment & Supplies Industry Quick RatioOct 02 2026 MRQ Cash & cash equivalentOct 02 2026 MRQ Current Liabilities
3m Company  0.03 $ 322.000  Millions$ 11,868.000  Millions
Enovis Corp  0.02 $ 13.038  Millions$ 653.826  Millions
Stimcell Energetics Inc   0.02 $ 0.007  Millions$ 0.383  Millions

Date modified: 2026-11-07T13:19:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.